Baird analyst David Koning downgrades Verra Mobility (NASDAQ:VRRM) from Outperform to Neutral.
SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $34
SVB Leerink analyst Joseph Schwartz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and raises the price target from $33 to $34.